Xiong, Y., Shao, L., Liu, J., Zhou, Q., Li, C., Liao, M., . . . Lei, X. (2021). The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine. Frontiers Media S.A.
Style de citation Chicago (17e éd.)Xiong, Yanli, et al. The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine. Frontiers Media S.A, 2021.
Style de citation MLA (8e éd.)Xiong, Yanli, et al. The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine. Frontiers Media S.A, 2021.